TD Securities analyst Jonathan Kelcher upgraded Extendicare (EXETF) to Buy from Hold with a price target of C$32, up from C$19, after resuming coverage. The firm cites a more favorable view of the growth potential of Extendicare’s home healthcare business for the upgrade. Consensus estimates may still be too low, especially if the company can find additional tuck in acquisitions, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXETF:
- Extendicare upgraded to Buy from Hold at TD Securities
- Extendicare’s ParaMed Closes $570 Million Acquisition of CBI Home Health
- Extendicare refreshes board as it deepens shift to health services
- Extendicare Declares March 2026 Dividend, Signals Confidence in Senior-Care Operations
- Extendicare price target raised to C$30 from C$25 at RBC Capital